ArticleOncotarget2017

IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.

Sonja M Kessler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.